Sanofi
Sanofi reported 10 stocks worth $534M in its 13F filing for Q2 2026, filed Jul 28, 2026. Its largest holdings are MGTX (30.9%), INBX (20.5%) and NVAX (12.1%). Compared with Q1 2026, the fund opened new positions in ODTX and TRAX and sold out of ELDN.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 7 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  MGTX Meiragtx Hldgs PLC | $165M | 30.9% | 12.2M | No change | 7 of 7 | |
| 2 |  INBX Inhibrx Biosciences Inc | $110M | 20.5% | 1.2M | No change | 7 of 7 | |
| 3 |  NVAX Novavax Inc | $64.8M | 12.1% | 6.9M | No change | 7 of 7 | |
| 4 |  ANAB Anaptysbio Inc | $55.5M | 10.4% | 822K | No change | 7 of 7 | |
| 5 |  ODTX Odyssey Therapeutics, Inc. | $37.3M | 7.0% | 2M | New position | 1 of 7 | |
| 6 |  AGMB Agomab Therapeutics NV | $36.1M | 6.8% | 2.8M | No change | 2 of 7 | |
| 7 |  MPLT Maplight Therapeutics Inc | $32.7M | 6.1% | 912K | No change | 3 of 7 | |
| 8 |  TRAX First Tracks Biotherapeutics | $16.5M | 3.1% | 822K | New position | 1 of 7 | |
| 9 |  IMRX Immuneering Corp | $13.5M | 2.5% | 2.7M | No change | 4 of 7 | |
| 10 |  QTTB Q32 Bio Inc | $3.1M | 0.6% | 244K | No change | 7 of 7 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 ELDN Eledon Pharmaceuticals Inc | $2.5M | 815K |
Reported value
last 7 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Jul 28, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Sanofi 13F FAQ
What does Sanofi own?
Sanofi reported 10 stocks worth $534M in its 13F filing for Q2 2026, filed Jul 28, 2026. Its largest holdings are MGTX (30.9%), INBX (20.5%) and NVAX (12.1%). The table above lists every position in the filing (the top 10 without an account).
What did Sanofi buy and sell in Q2 2026?
Compared with Q1 2026: 2 new positions, 0 added to, 0 trimmed and 1 sold out. New positions include ODTX and TRAX. It sold all of ELDN.
When will Sanofi file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Sanofi's portfolio worth?
The Q2 2026 filing reports $534M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.